The global market for Swine Autogenous Vaccines was valued at US$ 434 million in the year 2024 and is projected to reach a revised size of US$ 607 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Swine Autogenous Vaccines Market

Swine autogenous vaccines are vaccines prepared using pathogen isolates from pig herds themselves, targeting specific pathogens or diseases in pig farms. The production process of these vaccines typically includes isolating pathogens from sick pigs, purifying and culturing them, and preparing vaccine antigens. Swine autogenous vaccines offer high degrees of specificity and adaptability, enabling more effective responses to specific disease issues in pig farms. Since the vaccine antigens are derived from pathogens within the pig herd, swine autogenous vaccines have unique advantages in stimulating the immune response of pigs, providing more effective immune protection.

North American market for Swine Autogenous Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Swine Autogenous Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Swine Autogenous Vaccines include San Vet, Bimeda Biologicals, Vaxxinova, Merck Animal Health, Boehringer Ingelheim, Phibro Animal Health Corporation, Dopharma, Ceva Biovac, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Autogenous Vaccines.

The Swine Autogenous Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Autogenous Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Swine Autogenous Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Swine Autogenous Vaccines Market Report

Report Metric	Details
Report Name	Swine Autogenous Vaccines Market
Accounted market size in year	US$ 434 million
Forecasted market size in 2031	US$ 607 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Respiratory System Vaccines Intestinal System Vaccines Reproductive System Vaccines Others
Segment by Application	Government Bidding Market Sales
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	San Vet, Bimeda Biologicals, Vaxxinova, Merck Animal Health, Boehringer Ingelheim, Phibro Animal Health Corporation, Dopharma, Ceva Biovac
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Swine Autogenous Vaccines Market growing?

Ans: The Swine Autogenous Vaccines Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Swine Autogenous Vaccines Market size in 2031?

Ans: The Swine Autogenous Vaccines Market size in 2031 will be US$ 607 million.

Who are the main players in the Swine Autogenous Vaccines Market report?

Ans: The main players in the Swine Autogenous Vaccines Market are San Vet, Bimeda Biologicals, Vaxxinova, Merck Animal Health, Boehringer Ingelheim, Phibro Animal Health Corporation, Dopharma, Ceva Biovac

What are the Application segmentation covered in the Swine Autogenous Vaccines Market report?

Ans: The Applications covered in the Swine Autogenous Vaccines Market report are Government Bidding, Market Sales

What are the Type segmentation covered in the Swine Autogenous Vaccines Market report?

Ans: The Types covered in the Swine Autogenous Vaccines Market report are Respiratory System Vaccines, Intestinal System Vaccines, Reproductive System Vaccines, Others

1 Swine Autogenous Vaccines Market Overview

1.1 Product Definition

1.2 Swine Autogenous Vaccines by Type

1.2.1 Global Swine Autogenous Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Respiratory System Vaccines

1.2.3 Intestinal System Vaccines

1.2.4 Reproductive System Vaccines

1.2.5 Others

1.3 Swine Autogenous Vaccines by Application

1.3.1 Global Swine Autogenous Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Government Bidding

1.3.3 Market Sales

1.4 Global Swine Autogenous Vaccines Market Size Estimates and Forecasts

1.4.1 Global Swine Autogenous Vaccines Revenue 2020-2031

1.4.2 Global Swine Autogenous Vaccines Sales 2020-2031

1.4.3 Global Swine Autogenous Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Swine Autogenous Vaccines Market Competition by Manufacturers

2.1 Global Swine Autogenous Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Swine Autogenous Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Swine Autogenous Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Swine Autogenous Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Swine Autogenous Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Swine Autogenous Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Swine Autogenous Vaccines, Date of Enter into This Industry

2.8 Global Swine Autogenous Vaccines Market Competitive Situation and Trends

2.8.1 Global Swine Autogenous Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Swine Autogenous Vaccines Players Market Share by Revenue

2.8.3 Global Swine Autogenous Vaccines Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Swine Autogenous Vaccines Market Scenario by Region

3.1 Global Swine Autogenous Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Swine Autogenous Vaccines Sales by Region: 2020-2031

3.2.1 Global Swine Autogenous Vaccines Sales by Region: 2020-2025

3.2.2 Global Swine Autogenous Vaccines Sales by Region: 2026-2031

3.3 Global Swine Autogenous Vaccines Revenue by Region: 2020-2031

3.3.1 Global Swine Autogenous Vaccines Revenue by Region: 2020-2025

3.3.2 Global Swine Autogenous Vaccines Revenue by Region: 2026-2031

3.4 North America Swine Autogenous Vaccines Market Facts & Figures by Country

3.4.1 North America Swine Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Swine Autogenous Vaccines Sales by Country (2020-2031)

3.4.3 North America Swine Autogenous Vaccines Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Swine Autogenous Vaccines Market Facts & Figures by Country

3.5.1 Europe Swine Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Swine Autogenous Vaccines Sales by Country (2020-2031)

3.5.3 Europe Swine Autogenous Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Swine Autogenous Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Swine Autogenous Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Swine Autogenous Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Swine Autogenous Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Swine Autogenous Vaccines Market Facts & Figures by Country

3.7.1 Latin America Swine Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Swine Autogenous Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Swine Autogenous Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Swine Autogenous Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Swine Autogenous Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Swine Autogenous Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Swine Autogenous Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Swine Autogenous Vaccines Sales by Type (2020-2031)

4.1.1 Global Swine Autogenous Vaccines Sales by Type (2020-2025)

4.1.2 Global Swine Autogenous Vaccines Sales by Type (2026-2031)

4.1.3 Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Swine Autogenous Vaccines Revenue by Type (2020-2031)

4.2.1 Global Swine Autogenous Vaccines Revenue by Type (2020-2025)

4.2.2 Global Swine Autogenous Vaccines Revenue by Type (2026-2031)

4.2.3 Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Swine Autogenous Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Swine Autogenous Vaccines Sales by Application (2020-2031)

5.1.1 Global Swine Autogenous Vaccines Sales by Application (2020-2025)

5.1.2 Global Swine Autogenous Vaccines Sales by Application (2026-2031)

5.1.3 Global Swine Autogenous Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Swine Autogenous Vaccines Revenue by Application (2020-2031)

5.2.1 Global Swine Autogenous Vaccines Revenue by Application (2020-2025)

5.2.2 Global Swine Autogenous Vaccines Revenue by Application (2026-2031)

5.2.3 Global Swine Autogenous Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Swine Autogenous Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 San Vet

6.1.1 San Vet Company Information

6.1.2 San Vet Description and Business Overview

6.1.3 San Vet Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 San Vet Swine Autogenous Vaccines Product Portfolio

6.1.5 San Vet Recent Developments/Updates

6.2 Bimeda Biologicals

6.2.1 Bimeda Biologicals Company Information

6.2.2 Bimeda Biologicals Description and Business Overview

6.2.3 Bimeda Biologicals Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bimeda Biologicals Swine Autogenous Vaccines Product Portfolio

6.2.5 Bimeda Biologicals Recent Developments/Updates

6.3 Vaxxinova

6.3.1 Vaxxinova Company Information

6.3.2 Vaxxinova Description and Business Overview

6.3.3 Vaxxinova Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Vaxxinova Swine Autogenous Vaccines Product Portfolio

6.3.5 Vaxxinova Recent Developments/Updates

6.4 Merck Animal Health

6.4.1 Merck Animal Health Company Information

6.4.2 Merck Animal Health Description and Business Overview

6.4.3 Merck Animal Health Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Animal Health Swine Autogenous Vaccines Product Portfolio

6.4.5 Merck Animal Health Recent Developments/Updates

6.5 Boehringer Ingelheim

6.5.1 Boehringer Ingelheim Company Information

6.5.2 Boehringer Ingelheim Description and Business Overview

6.5.3 Boehringer Ingelheim Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Boehringer Ingelheim Swine Autogenous Vaccines Product Portfolio

6.5.5 Boehringer Ingelheim Recent Developments/Updates

6.6 Phibro Animal Health Corporation

6.6.1 Phibro Animal Health Corporation Company Information

6.6.2 Phibro Animal Health Corporation Description and Business Overview

6.6.3 Phibro Animal Health Corporation Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Phibro Animal Health Corporation Swine Autogenous Vaccines Product Portfolio

6.6.5 Phibro Animal Health Corporation Recent Developments/Updates

6.7 Dopharma

6.7.1 Dopharma Company Information

6.7.2 Dopharma Description and Business Overview

6.7.3 Dopharma Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Dopharma Swine Autogenous Vaccines Product Portfolio

6.7.5 Dopharma Recent Developments/Updates

6.8 Ceva Biovac

6.8.1 Ceva Biovac Company Information

6.8.2 Ceva Biovac Description and Business Overview

6.8.3 Ceva Biovac Swine Autogenous Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Ceva Biovac Swine Autogenous Vaccines Product Portfolio

6.8.5 Ceva Biovac Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Swine Autogenous Vaccines Industry Chain Analysis

7.2 Swine Autogenous Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Swine Autogenous Vaccines Production Mode & Process Analysis

7.4 Swine Autogenous Vaccines Sales and Marketing

7.4.1 Swine Autogenous Vaccines Sales Channels

7.4.2 Swine Autogenous Vaccines Distributors

7.5 Swine Autogenous Vaccines Customer Analysis

8 Swine Autogenous Vaccines Market Dynamics

8.1 Swine Autogenous Vaccines Industry Trends

8.2 Swine Autogenous Vaccines Market Drivers

8.3 Swine Autogenous Vaccines Market Challenges

8.4 Swine Autogenous Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Phibro Animal Health Corporation

Dopharma

Ceva Biovac

List of Tables

Table 1. Global Swine Autogenous Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Swine Autogenous Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Swine Autogenous Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Swine Autogenous Vaccines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Swine Autogenous Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Swine Autogenous Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Swine Autogenous Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Swine Autogenous Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Swine Autogenous Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Swine Autogenous Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Swine Autogenous Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Swine Autogenous Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Swine Autogenous Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Autogenous Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Swine Autogenous Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Swine Autogenous Vaccines Sales by Region (2020-2025) & (K Units)

Table 18. Global Swine Autogenous Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Swine Autogenous Vaccines Sales by Region (2026-2031) & (K Units)

Table 20. Global Swine Autogenous Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Swine Autogenous Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Swine Autogenous Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Swine Autogenous Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Swine Autogenous Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Swine Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)

Table 27. North America Swine Autogenous Vaccines Sales by Country (2026-2031) & (K Units)

Table 28. North America Swine Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Swine Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Swine Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Swine Autogenous Vaccines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Swine Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Swine Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Swine Autogenous Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Swine Autogenous Vaccines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Swine Autogenous Vaccines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Swine Autogenous Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Swine Autogenous Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Swine Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Swine Autogenous Vaccines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Swine Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Swine Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Swine Autogenous Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Swine Autogenous Vaccines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Swine Autogenous Vaccines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Swine Autogenous Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Swine Autogenous Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Swine Autogenous Vaccines Sales (K Units) by Type (2020-2025)

Table 51. Global Swine Autogenous Vaccines Sales (K Units) by Type (2026-2031)

Table 52. Global Swine Autogenous Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Swine Autogenous Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Swine Autogenous Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Swine Autogenous Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Swine Autogenous Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Swine Autogenous Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Swine Autogenous Vaccines Price (US$/Unit) by Type (2020-2025)

Table 59. Global Swine Autogenous Vaccines Price (US$/Unit) by Type (2026-2031)

Table 60. Global Swine Autogenous Vaccines Sales (K Units) by Application (2020-2025)

Table 61. Global Swine Autogenous Vaccines Sales (K Units) by Application (2026-2031)

Table 62. Global Swine Autogenous Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Swine Autogenous Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Swine Autogenous Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Swine Autogenous Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Swine Autogenous Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Swine Autogenous Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Swine Autogenous Vaccines Price (US$/Unit) by Application (2020-2025)

Table 69. Global Swine Autogenous Vaccines Price (US$/Unit) by Application (2026-2031)

Table 70. San Vet Company Information

Table 71. San Vet Description and Business Overview

Table 72. San Vet Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. San Vet Swine Autogenous Vaccines Product

Table 74. San Vet Recent Developments/Updates

Table 75. Bimeda Biologicals Company Information

Table 76. Bimeda Biologicals Description and Business Overview

Table 77. Bimeda Biologicals Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Bimeda Biologicals Swine Autogenous Vaccines Product

Table 79. Bimeda Biologicals Recent Developments/Updates

Table 80. Vaxxinova Company Information

Table 81. Vaxxinova Description and Business Overview

Table 82. Vaxxinova Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Vaxxinova Swine Autogenous Vaccines Product

Table 84. Vaxxinova Recent Developments/Updates

Table 85. Merck Animal Health Company Information

Table 86. Merck Animal Health Description and Business Overview

Table 87. Merck Animal Health Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Merck Animal Health Swine Autogenous Vaccines Product

Table 89. Merck Animal Health Recent Developments/Updates

Table 90. Boehringer Ingelheim Company Information

Table 91. Boehringer Ingelheim Description and Business Overview

Table 92. Boehringer Ingelheim Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Boehringer Ingelheim Swine Autogenous Vaccines Product

Table 94. Boehringer Ingelheim Recent Developments/Updates

Table 95. Phibro Animal Health Corporation Company Information

Table 96. Phibro Animal Health Corporation Description and Business Overview

Table 97. Phibro Animal Health Corporation Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Phibro Animal Health Corporation Swine Autogenous Vaccines Product

Table 99. Phibro Animal Health Corporation Recent Developments/Updates

Table 100. Dopharma Company Information

Table 101. Dopharma Description and Business Overview

Table 102. Dopharma Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Dopharma Swine Autogenous Vaccines Product

Table 104. Dopharma Recent Developments/Updates

Table 105. Ceva Biovac Company Information

Table 106. Ceva Biovac Description and Business Overview

Table 107. Ceva Biovac Swine Autogenous Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Ceva Biovac Swine Autogenous Vaccines Product

Table 109. Ceva Biovac Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Swine Autogenous Vaccines Distributors List

Table 113. Swine Autogenous Vaccines Customers List

Table 114. Swine Autogenous Vaccines Market Trends

Table 115. Swine Autogenous Vaccines Market Drivers

Table 116. Swine Autogenous Vaccines Market Challenges

Table 117. Swine Autogenous Vaccines Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Swine Autogenous Vaccines

Figure 2. Global Swine Autogenous Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Swine Autogenous Vaccines Market Share by Type: 2024 & 2031

Figure 4. Respiratory System Vaccines Product Picture

Figure 5. Intestinal System Vaccines Product Picture

Figure 6. Reproductive System Vaccines Product Picture

Figure 7. Others Product Picture

Figure 8. Global Swine Autogenous Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Swine Autogenous Vaccines Market Share by Application: 2024 & 2031

Figure 10. Government Bidding

Figure 11. Market Sales

Figure 12. Global Swine Autogenous Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Swine Autogenous Vaccines Market Size (2020-2031) & (US$ Million)

Figure 14. Global Swine Autogenous Vaccines Sales (2020-2031) & (K Units)

Figure 15. Global Swine Autogenous Vaccines Average Price (US$/Unit) & (2020-2031)

Figure 16. Swine Autogenous Vaccines Report Years Considered

Figure 17. Swine Autogenous Vaccines Sales Share by Manufacturers in 2024

Figure 18. Global Swine Autogenous Vaccines Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Swine Autogenous Vaccines Players: Market Share by Revenue in Swine Autogenous Vaccines in 2024

Figure 20. Swine Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Swine Autogenous Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Swine Autogenous Vaccines Sales Market Share by Country (2020-2031)

Figure 23. North America Swine Autogenous Vaccines Revenue Market Share by Country (2020-2031)

Figure 24. United States Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Swine Autogenous Vaccines Sales Market Share by Country (2020-2031)

Figure 27. Europe Swine Autogenous Vaccines Revenue Market Share by Country (2020-2031)

Figure 28. Germany Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Swine Autogenous Vaccines Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Swine Autogenous Vaccines Revenue Market Share by Region (2020-2031)

Figure 35. China Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Swine Autogenous Vaccines Sales Market Share by Country (2020-2031)

Figure 43. Latin America Swine Autogenous Vaccines Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Swine Autogenous Vaccines Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Swine Autogenous Vaccines Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Swine Autogenous Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Swine Autogenous Vaccines by Type (2020-2031)

Figure 54. Global Revenue Market Share of Swine Autogenous Vaccines by Type (2020-2031)

Figure 55. Global Swine Autogenous Vaccines Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Swine Autogenous Vaccines by Application (2020-2031)

Figure 57. Global Revenue Market Share of Swine Autogenous Vaccines by Application (2020-2031)

Figure 58. Global Swine Autogenous Vaccines Price (US$/Unit) by Application (2020-2031)

Figure 59. Swine Autogenous Vaccines Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Swine Vaccines Market Insights Forecast to 2030

Veterinary Autogenous Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Autogenous Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock mRNA Vaccines Market Research Report 2025

Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Animal Vaccines Market Research Report 2024

Global Livestock Animal Vaccination Market Research Report 2025

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Insights Forecast to 2030

Global Livestock Vaccines Market Research Report 2025

Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Vaccine Market

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Custom Swine Vaccines Market Research Report 2025

Global Travelers Vaccines Market Research Report 2025

Global Live Attenuated Vaccine for Pig Market Research Report 2024

Global Veterinary mRNA Vaccines Market Research Report 2025

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions